Cancer Immunology, Immunotherapy Issues Research Articles in September 2023 Edition
August 11, 2023
August 11, 2023
BASEL, Switzerland, Aug. 11 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles, including the following topics, in its September 2023 edition:
Research:
* A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
* Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HE . . .
Research:
* A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma
* Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HE . . .